SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-17-015866
Filing Date
2017-03-21
Accepted
2017-03-21 16:33:37
Documents
60
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v462321_10ka.htm 10-K/A 337900
2 EXHIBIT 31.1 v462321_ex31-1.htm EX-31.1 8432
3 EXHIBIT 31.2 v462321_ex31-2.htm EX-31.2 8310
4 EXHIBIT 32.1 v462321_ex32-1.htm EX-32.1 4201
5 EXHIBIT 32.2 v462321_ex32-2.htm EX-32.2 4153
  Complete submission text file 0001144204-17-015866.txt   3958368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001651407-20161231.xml EX-101.INS 841045
7 XBRL TAXONOMY EXTENSION SCHEMA ck0001651407-20161231.xsd EX-101.SCH 42020
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001651407-20161231_cal.xml EX-101.CAL 32600
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001651407-20161231_def.xml EX-101.DEF 275824
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001651407-20161231_lab.xml EX-101.LAB 294817
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001651407-20161231_pre.xml EX-101.PRE 320067
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55506 | Film No.: 17704551
SIC: 2834 Pharmaceutical Preparations